Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GD2 CAR-T for GD2 Positive Glioma
NCT04406610Phase 2Withdrawn
- Sponsor
- Fuda Cancer Hospital
- Start
- Sep 2015
- Primary completion
- Aug 2016
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
01
Overview
A Phase 2 trial of GD2 CAR T in glioma, sponsored by Fuda Cancer Hospital. Planned start Sep 2015; status: withdrawn.
02
Drugs
GD2 CAR T
03
Conditions
glioma
Beyond the preview
Go deeper on NCT04406610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04406610.